Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The thromboxane A2 receptor (TP) is a G protein-coupled receptor that mediates the actions of thromboxane A2 (TXA2), a potent eicosanoid involved in platelet aggregation, vasoconstriction, and various inflammatory responses. It is a key target for antithrombotic therapies.
Thromboxane A2 receptor antagonists block the binding of thromboxane A2 to the TP receptor, thereby inhibiting platelet aggregation, vasoconstriction, and other downstream effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thromboxane A2 Receptor (TP).